These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 28915934)
1. Increased YAP Activation Is Associated With Hepatic Cyst Epithelial Cell Proliferation in ARPKD/CHF. Jiang L; Sun L; Edwards G; Manley M; Wallace DP; Septer S; Manohar C; Pritchard MT; Apte U Gene Expr; 2017 Nov; 17(4):313-326. PubMed ID: 28915934 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of Mast Cell Degranulation With Cromolyn Sodium Exhibits Organ-Specific Effects in Polycystic Kidney (PCK) Rats. Jiang L; Fang P; Septer S; Apte U; Pritchard MT Int J Toxicol; 2018; 37(4):308-326. PubMed ID: 29862868 [TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system activation in congenital hepatic fibrosis in the PCK rat model of autosomal recessive polycystic kidney disease. Goto M; Hoxha N; Osman R; Wen J; Wells RG; Dell KM J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):639-44. PubMed ID: 20400910 [TBL] [Abstract][Full Text] [Related]
4. Taurocholate Induces Connective Tissue Growth Factor Expression in Hepatocytes Through ERK-YAP Signaling. Yu B; Jin GN; Ma M; Liang HF; Zhang BX; Chen XP; Ding ZY Cell Physiol Biochem; 2018; 50(5):1711-1725. PubMed ID: 30384360 [TBL] [Abstract][Full Text] [Related]
5. The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD). Banales JM; Masyuk TV; Gradilone SA; Masyuk AI; Medina JF; LaRusso NF Hepatology; 2009 Jan; 49(1):160-74. PubMed ID: 19065671 [TBL] [Abstract][Full Text] [Related]
6. Altered Hippo signalling in polycystic kidney disease. Happé H; van der Wal AM; Leonhard WN; Kunnen SJ; Breuning MH; de Heer E; Peters DJ J Pathol; 2011 May; 224(1):133-42. PubMed ID: 21381034 [TBL] [Abstract][Full Text] [Related]
7. Evidence for a "Pathogenic Triumvirate" in Congenital Hepatic Fibrosis in Autosomal Recessive Polycystic Kidney Disease. Jiang L; Fang P; Weemhoff JL; Apte U; Pritchard MT Biomed Res Int; 2016; 2016():4918798. PubMed ID: 27891514 [TBL] [Abstract][Full Text] [Related]
8. Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease. Yoshihara D; Kugita M; Sasaki M; Horie S; Nakanishi K; Abe T; Aukema HM; Yamaguchi T; Nagao S PLoS One; 2013; 8(12):e81480. PubMed ID: 24324698 [TBL] [Abstract][Full Text] [Related]
9. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate. Masyuk TV; Masyuk AI; Torres VE; Harris PC; Larusso NF Gastroenterology; 2007 Mar; 132(3):1104-16. PubMed ID: 17383431 [TBL] [Abstract][Full Text] [Related]
10. Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD. Gradilone SA; Masyuk TV; Huang BQ; Banales JM; Lehmann GL; Radtke BN; Stroope A; Masyuk AI; Splinter PL; LaRusso NF Gastroenterology; 2010 Jul; 139(1):304-14.e2. PubMed ID: 20399209 [TBL] [Abstract][Full Text] [Related]
11. Recent progress in the etiopathogenesis of pediatric biliary disease, particularly Caroli's disease with congenital hepatic fibrosis and biliary atresia. Nakanuma Y; Harada K; Sato Y; Ikeda H Histol Histopathol; 2010 Feb; 25(2):223-35. PubMed ID: 20017109 [TBL] [Abstract][Full Text] [Related]
12. Loss of fibrocystin promotes interleukin-8-dependent proliferation and CTGF production of biliary epithelium. Tsunoda T; Kakinuma S; Miyoshi M; Kamiya A; Kaneko S; Sato A; Tsuchiya J; Nitta S; Kawai-Kitahata F; Murakawa M; Itsui Y; Nakagawa M; Azuma S; Sogo T; Komatsu H; Mukouchi R; Inui A; Fujisawa T; Nakauchi H; Asahina Y; Watanabe M J Hepatol; 2019 Jul; 71(1):143-152. PubMed ID: 30898581 [TBL] [Abstract][Full Text] [Related]
13. Global Transcriptomics of Congenital Hepatic Fibrosis in Autosomal Recessive Polycystic Kidney Disease using PCK rats. Khare S; Jiang L; Cabrara DP; Apte U; Pritchard MT bioRxiv; 2023 Jan; ():. PubMed ID: 36711494 [TBL] [Abstract][Full Text] [Related]
14. Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease. Masyuk T; Masyuk A; Trussoni C; Howard B; Ding J; Huang B; LaRusso N JHEP Rep; 2021 Oct; 3(5):100345. PubMed ID: 34568801 [TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1 Fabris L; Milani C; Fiorotto R; Mariotti V; Kaffe E; Seller B; Sonzogni A; Strazzabosco M; Cadamuro M FASEB J; 2022 Jun; 36(6):e22364. PubMed ID: 35593740 [TBL] [Abstract][Full Text] [Related]
16. Tissue culture correlational study of genetic cholangiopathy of autosomal recessive polycystic kidney disease. Nakanuma Y; Sato Y; Harada K Methods Mol Biol; 2013; 945():303-18. PubMed ID: 23097114 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. Lee SO; Masyuk T; Splinter P; Banales JM; Masyuk A; Stroope A; Larusso N J Clin Invest; 2008 Nov; 118(11):3714-24. PubMed ID: 18949056 [TBL] [Abstract][Full Text] [Related]
19. A role for Hippo/YAP-signaling in FGF-induced lens epithelial cell proliferation and fibre differentiation. Dawes LJ; Shelley EJ; McAvoy JW; Lovicu FJ Exp Eye Res; 2018 Apr; 169():122-133. PubMed ID: 29355736 [TBL] [Abstract][Full Text] [Related]
20. Biliary infection may exacerbate biliary cystogenesis through the induction of VEGF in cholangiocytes of the polycystic kidney (PCK) rat. Ren XS; Sato Y; Harada K; Sasaki M; Yoneda N; Lin ZH; Nakanuma Y Am J Pathol; 2011 Dec; 179(6):2845-54. PubMed ID: 22015458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]